We deliver quality biomaterials with expert support
With over 80 years of combined biomaterials experience across our executive team, APS is uniquely positioned to offer medical device manufacturers a tailored alternative to the large corporate suppliers currently in the market.
what sets us apart
We provide flexible, fit-for-purpose solutions designed to support both our clients’ current needs and future growth.
Our commitment to innovation, both internally and in collaboration with leading medical institutions, enables us to deliver high-quality, biocompatible products that support advances in regenerative medicine and medical device manufacturing.
APS has been building strong relationships with abattoirs and supporting medical device companies of all sizes since 2023.
We have now grown into a premium biomaterial supplier focused on helping bring high-quality medical devices to market. Drawing on a depth of industry expertise across tissue sourcing, medical technology and regulatory processes, we provide value far beyond supply alone.
From paddock to patient, we are the partner connecting tissue to technology.
Our approach
Today, APS provides medical device companies with quality xenograft tissues and the expertise needed to bring successful devices to market.
Crystal Anderson-Cunanan|CTO
With more than 40 years of experience in biomaterials, Crystal brings a wealth of expertise to the APS team in her role as Chief Technical Officer and is responsible for designing and developing the processes used by APS to harvest and process tissues for our clients. Crystal has played a significant role in shaping international standards and regulatory guidance, including contributing as a scientific writer to the original BSE Pathogenesis study adopted by the World Health Organisation as the Tables of Tissue Infectivity. Crystal has also served on the AAMI Tissue Safety Committee and worked with the FDA and European regulators to support updates to the ISO 22442 standards. Crystal brings to APS extensive experience across supplier selection and qualification, process definition, review, and validation, tissue characterisation studies, preclinical small and large animal studies, biocompatibility testing, viral inactivation studies, and EDQM submissions. Trained as a chemist, Crystal also has over 50 US patents and applications focused on the development and commercialisation of Class III implantable devices, and has worked for Edwards Lifesciences, Boston Scientific, Allergan (now Abbvie), and numerous start-up medtech companies. She is also an elected member to the College of Fellows, American Institute of Medical & Biomedical Engineers.
.jpg)
Nick Dobbie|COO
Nick is an experienced professional in the medical technology sector, with expertise spanning engineering, operations, and quality management. Following completion of his engineering degree, he joined Canadian cardiovascular device company Neovasc Inc., where he managed the development of transcatheter heart valves from concept through to first-in-human trials. He has extensive experience in quality management, including formal training as an ISO 13485 auditor through BSI Group. He has conducted audits of medical device manufacturers across North America, China, Australia, and New Zealand, as well as auditing multiple tissue suppliers against ISO 22442. Nick’s focus on operational excellence led to him founding Acorn Neurodiversity, which became New Zealand’s largest provider of autism therapy services. He subsequently grew and sold the business. More recently, as General Manager and Director of Engineering at Rex Bionics, he led production, engineering, and administrative functions for a Class II Robotic Exoskeleton medical device. At APS, Nick is proud to lead the operations team while utilising his technical product knowledge, commercial discipline in production, and expertise in quality management of animal-derived materials.
Ben Rogers|CEO
With 23 years of diverse experience within the medical device sector, including 9 years with Maverick Bio where his roles included CEO, COO and GM, Ben is known and respected internationally for his calm and people-focused leadership style. Holding a Bachelor of Business (Management) and a Diploma of Laboratory Technology, he brings to APS a breadth of experience across supply chain, operations, commercial, quality systems, and product development, and believes that cross-functional collaboration with all stakeholders ensures built-in quality and scalable solutions that can be relied upon throughout the entire medical device lifecycle.
.jpg)
Kevin Darling|CCO
Kevin is an experienced executive in the medical technology and biotechnology sectors, with expertise in global tissue supply, commercial strategy and operational leadership. After beginning his career with BOC Gases in the United Kingdom, he later went on to hold commercial management positions with several multinational blue chip companies including Mars and 3M. Following a move to New Zealand, Kevin became Group General Manager (Australasia) for Gribbles Veterinary Pathology and joined the Healthscope New Zealand executive team. He later joined Collagen Solutions, progressing to Vice President of Global Tissue Supply, where he led the sourcing and global sale of bovine and porcine tissues and collagen-based products for medical device companies across the globe. Kevin has worked across the United Kingdom, New Zealand, Australia and the United States, and is well connected with biomaterials suppliers and clients across the U.S., European, Chinese and South Korean biotechnology markets. He has now brought his expertise to APS, supporting global supply chain development, industry partnerships and the growth of APS’ co-products business in his role as Chief Commercial Officer.
our team
If you work in biomaterials, you should already know our team.
APS is led by a group of industry veterans with decades of experience in biomaterials, medical devices, and compliance. Our leadership has worked across the full lifecycle of animal-derived tissues, from sourcing, processing, and device design through to validation, regulatory approval, and clinical use.
Quality & compliance
APS brings extensive expertise of the quality and regulatory requirements involved in the medical technology industry. We uphold rigorous quality and compliance standards, including ISO 13485 and ISO 22442, to ensure our products meet global regulatory requirements.
Our team of experts understands the requirements for bringing products to market nationally and internationally, and can provide guidance on quality systems, audits, testing, submissions and the controls needed to ensure compliance at every stage.
